IntegriChain, a leader in pharma revenue optimization technology, is set to host its annual Revenue Analytics Collaborative (RAC) Summit on March 27, 2025, in East Brunswick, NJ. This complimentary event is tailored for pharmaceutical manufacturers aiming to navigate industry challenges and regulations concerning pricing and reimbursement. Jeff Baab, a Partner in IntegriChain’s Consulting and Advisory practice, will deliver the keynote address, shedding light on the significant policy, pricing, and reimbursement pressures confronting pharmaceutical professionals. The summit will also feature a fireside chat with Kristen Landon, Chief Commercial Officer of 60 Degrees Pharmaceuticals, who will share insights from her extensive 25-year career.
Also Read: Cymulate Unveils AI-Powered Automation for Threat Validation
Attendees can participate in 12 roundtable discussions covering pressing topics such as the Inflation Reduction Act (IRA), Medicare Part D redesign, 340B developments, and strategic net revenue modeling. Jen Sharpe, RAC facilitator and Vice President in IntegriChain’s Consulting and Advisory practice, emphasized the event’s value: “The RAC Summit is a can’t-miss event for any Pharma/Biotech business or finance professional… The positive spirit of the event is simply unparalleled, and the insights delivered are tremendously valuable to all participants.” The RAC, sponsored by IntegriChain, is a private networking and benchmarking group comprising over 850 industry professionals from more than 275 manufacturers, dedicated to fostering collaboration and knowledge sharing in the pharmaceutical sector.